Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cystoscopic correction of reflux.

Richard Schlussel1

  • 1Children's Hospital of New York-Presbyterian, Department of Urology, 3959 Broadway, CHN-1118, New York, NY 10032, USA. rns2107@columbia.edu

Current Urology Reports
|March 19, 2004
PubMed
Summary

Endoscopic injection offers a less invasive treatment for childhood vesicoureteral reflux (VUR). New agents show promise, potentially reducing renal damage and increasing the role of minimally invasive VUR management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of the refractory nocturnal enuresis patient to desmopressin in a pediatric population: Desmopressin + oxybutynin vs. desmopressin + imipramine.

Journal of pediatric urology·2024
Same author

A comparison of 467 uroflowmetry results in repaired hypospadias vs. normal male flows.

Journal of pediatric urology·2024
Same author

New onset urinary incontinence in a pediatric patient with transverse myelitis.

Urology case reports·2023
Same author

EDITORIAL COMMENT.

Urology·2021
Same author

EDITORIAL COMMENT.

Urology·2019
Same author

Editorial Comment.

Urology·2019

Area of Science:

  • Pediatric Urology
  • Minimally Invasive Surgery
  • Biomaterials in Medicine

Background:

  • Vesicoureteral reflux (VUR) is a significant cause of pediatric illness and kidney damage.
  • Historically, surgical reimplantation was the primary treatment for VUR.
  • The development of endoscopic injection techniques emerged as a less invasive alternative.

Purpose of the Study:

  • To review the evolution and efficacy of injectable agents for endoscopic management of VUR.
  • To compare early agents like Teflon with newer materials such as polydimethylsiloxane and dextranomer polymer.
  • To assess the safety and effectiveness of minimally invasive VUR treatments.

Main Methods:

  • Review of historical and current injectable materials used in VUR treatment.
  • Analysis of efficacy and patient tolerance data for different agents.
  • Evaluation of safety profiles, including concerns about migration and side effects.

Main Results:

  • Teflon demonstrated efficacy and tolerance but raised concerns about migration.
  • Newer agents, polydimethylsiloxane and dextranomer polymer, appear effective and safe.
  • Long-term follow-up data for newer agents are still limited compared to Teflon.

Conclusions:

  • Endoscopic management is increasingly important for VUR treatment.
  • Newer injectable agents offer promising alternatives to traditional surgery.
  • The choice of the optimal injectable agent for VUR will be determined by long-term outcomes.

Related Experiment Videos